DE3272114D1 - 4-(4-phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones - Google Patents

4-(4-phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones

Info

Publication number
DE3272114D1
DE3272114D1 DE8282103743T DE3272114T DE3272114D1 DE 3272114 D1 DE3272114 D1 DE 3272114D1 DE 8282103743 T DE8282103743 T DE 8282103743T DE 3272114 T DE3272114 T DE 3272114T DE 3272114 D1 DE3272114 D1 DE 3272114D1
Authority
DE
Germany
Prior art keywords
imidazol
dihydro
piperidinyl
acyl
ones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8282103743T
Other languages
English (en)
Inventor
J Martin Grisar
Richard C Dage
Richard A Schnettler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3272114D1 publication Critical patent/DE3272114D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE8282103743T 1981-05-04 1982-05-03 4-(4-phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones Expired DE3272114D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/260,449 US4329471A (en) 1981-05-04 1981-05-04 4-(4-Phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones

Publications (1)

Publication Number Publication Date
DE3272114D1 true DE3272114D1 (de) 1986-08-28

Family

ID=22989212

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8282103743T Expired DE3272114D1 (de) 1981-05-04 1982-05-03 4-(4-phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones

Country Status (10)

Country Link
US (1) US4329471A (de)
EP (1) EP0064707B1 (de)
JP (1) JPS57185281A (de)
AT (1) ATE20891T1 (de)
AU (1) AU546960B2 (de)
CA (1) CA1167848A (de)
DE (1) DE3272114D1 (de)
ES (1) ES8308871A1 (de)
IL (1) IL65667A (de)
ZA (1) ZA822987B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
IT1230703B (it) * 1989-01-26 1991-10-29 Luso Farmaco Inst Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US2441936A (en) * 1946-03-22 1948-05-18 Hoffmann La Roche Imidazolones and method of preparation
US2514380A (en) * 1946-12-26 1950-07-11 Hoffmann La Roche Diamines and method of production
US3303199A (en) * 1963-07-15 1967-02-07 Geigy Chem Corp Certain imidazolone derivatives and process for making same
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions

Also Published As

Publication number Publication date
EP0064707B1 (de) 1986-07-23
ES511873A0 (es) 1983-10-01
CA1167848A (en) 1984-05-22
JPH0261475B2 (de) 1990-12-20
IL65667A0 (en) 1982-08-31
EP0064707A1 (de) 1982-11-17
AU546960B2 (en) 1985-09-26
US4329471A (en) 1982-05-11
ZA822987B (en) 1983-03-30
IL65667A (en) 1985-12-31
ATE20891T1 (de) 1986-08-15
JPS57185281A (en) 1982-11-15
AU8317682A (en) 1982-11-11
ES8308871A1 (es) 1983-10-01

Similar Documents

Publication Publication Date Title
DE3272114D1 (de) 4-(4-phenyl-1-piperidinyl)methyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
DE3270566D1 (de) 4-aminomethyl-5-acyl-1,3-dihydro-2h-imidazol-2-ones
ATE14125T1 (de) 5-(4-phenyl-1-piperidinyl)methyl-2,3-dihydro-2oxo-1h-imidazol-4-carbonsaeure-derivate.
DK47082A (da) Fremgangsmaade til fremstilling af bis- og polydisulfider
DE3271756D1 (de) 5-oxymethyl-4-acyl-1,3-dihydro-2h-imidazol-2-ones
DE3271755D1 (en) 5-aminomethyl-2,3-dihydro-2-oxo-1h-imidazole-4-carboxylic acid derivatives
SU1266156A1 (ru) 7-морфолинокумарины в качестве красителей для лазерной техники
SU820186A1 (ru) 1-[4-(3',4'-диоксифенил)-тиазолил-2]-3-алкил-5-тетрафторэтилпиразолы, обладающие акарицидной активностью
TH1794EX (th) เตตราไฮโดรไธโอไพแรน-3,5-ไดโอน-4-คาร์บอกซามีดที่ถูกแทนที่
SU1690242A1 (ru) Антифидант

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee